MedPage Today: Autopsies Turn Up Strange Feature of COVID-19 Lungs
UC cardiologist says COVID-19 also leads to blood clots
Richard Becker, MD, director of the UC Heart, Lung and Vascular Institute, discussed the impact COVID-19 is having on the lungs and cardiovascular system of patients during an interview with MedPage Today. Becker’s recent research publication on of COVID-19-associate coagulopathy in the Journal of Thrombosis and Thrombolysis was also cited.
COVID-19 lungs in deceased showed severe endothelial injury associated with the presence of intracellular virus and disrupted cell membranes. This evidence of virus in endothelial cells "suggests there is a direct cause and effect for the virus in this very profound inflammatory response and thrombosis response,” explains Becker, also a UC Health cardiologist during his interview with Medpage Today.
The Medpage Today interview is available online.
The latest research from Richard Becker, MD, is also available online.
Becker was also featured discussing blood clots and COVID-19 on a segment on Cincinnati's Local 12 News.
Featured image at top: Richard Becker, MD, (center) shown with colleague. Photo/Colleen Kelley/UC Creative + Brand.
Related Stories
Why so much hype around the new Grand Theft Auto?
November 6, 2026
UC experts from DAAP's game and animation program to a doctor at the Lindner Center of HOPE discuss the pros and cons surrounding the upcoming billion-dollar game Grand Theft Auto VI.
Are you experiencing “post-election stress disorder”?
November 6, 2026
Feelings of stress and anxiety tied to election results can persist even after the votes are counted, said University of Cincinnati psychiatrist Julia Stimpfl, MD, even though “post-election stress disorder” is not officially recognized as a mental illness. As she recently told Spectrum News 1 Ohio, those feelings can linger even after an election is finalized.
New UC research identifies biological differences in pancreatic cancer
November 6, 2026
University of Cincinnati Cancer Center research published in Cancer Research found differences in pancreatic cancer tumors and immune environments, opening the possibility for more personalized treatments.